STOCK TITAN

[SCHEDULE 13G] Neogen Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Gates Capital and related entities report beneficial ownership of 12,793,941 shares of Neogen Corporation common stock, equal to 5.9% of the 217,205,186 shares outstanding as of June 30, 2025. The filing lists Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; and Jeffrey L. Gates as joint reporting persons, each disclosing shared voting and dispositive power over the same 12,793,941 shares and no sole voting or dispositive power. The statement affirms the shares were acquired in the ordinary course of business and not to influence control of the issuer. The filing includes a joint filing agreement signed August 14, 2025.

Gates Capital e le entità correlate dichiarano la titolarità effettiva di 12.793.941 azioni ordinarie di Neogen Corporation, pari al 5,9% delle 217.205.186 azioni in circolazione al 30 giugno 2025. La comunicazione elenca Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; e Jeffrey L. Gates come soggetti che rendono la dichiarazione congiunta, ognuno dei quali dichiara di avere potere di voto e potere dispositivi condivisi sulle stesse 12.793.941 azioni e di non detenere alcun potere di voto o dispositivo in via esclusiva. La dichiarazione conferma che le azioni sono state acquisite nell'ambito dell'ordinaria attività d'impresa e non con l'intento di influenzare il controllo dell'emittente. Il deposito include un accordo di deposito congiunto firmato il 14 agosto 2025.

Gates Capital y entidades relacionadas informan la titularidad beneficiaria de 12.793.941 acciones ordinarias de Neogen Corporation, equivalentes al 5,9% de las 217.205.186 acciones en circulación al 30 de junio de 2025. La presentación enumera a Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; y Jeffrey L. Gates como informantes conjuntos, cada uno declarando tener poderes de voto y dispositivos compartidos sobre las mismas 12.793.941 acciones y no tener ningún poder de voto o dispositvo en forma exclusiva. La declaración afirma que las acciones se adquirieron en el curso ordinario del negocio y no con la intención de influir en el control del emisor. La presentación incluye un acuerdo de presentación conjunta firmado el 14 de agosto de 2025.

Gates Capital 및 관련 법인들은 네오젠 코퍼레이션 보통주 12,793,941주를 실질 소유하고 있음을 보고했으며, 이는 2025년 6월 30일 기준 발행주식 217,205,186주의 5.9%에 해당합니다. 신고서에는 Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; 및 Jeffrey L. Gates가 공동보고인으로 기재되어 있으며, 각자는 동일한 12,793,941주에 대해 공동 의결권 및 처분권을 보유하고 단독 의결권 또는 단독 처분권은 없다고 밝혔습니다. 성명서는 해당 주식이 통상적인 영업 과정에서 취득된 것이며 발행인의 지배에 영향을 미치기 위한 것이 아님을 확인합니다. 제출서에는 2025년 8월 14일 서명된 공동 제출 계약서가 포함되어 있습니다.

Gates Capital et des entités affiliées déclarent la propriété bénéficiaire de 12 793 941 actions ordinaires de Neogen Corporation, soit 5,9% des 217 205 186 actions en circulation au 30 juin 2025. Le dépôt mentionne Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; et Jeffrey L. Gates comme personnes faisant une déclaration conjointe, chacune déclarant détenir le pouvoir de vote et le pouvoir de disposition partagés sur les mêmes 12 793 941 actions et ne détenir aucun pouvoir de vote ni de disposition exclusif. La déclaration affirme que les actions ont été acquises dans le cours normal des affaires et non dans le but d'influencer le contrôle de l'émetteur. Le dossier inclut un accord de dépôt conjoint signé le 14 août 2025.

Gates Capital und verbundene Unternehmen melden ein wirtschaftliches Eigentum an 12.793.941 Stammaktien der Neogen Corporation, was 5,9% der 217.205.186 zum 30. Juni 2025 ausstehenden Aktien entspricht. Die Meldung führt Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; und Jeffrey L. Gates als gemeinsam meldende Personen auf, wobei jede Partei angibt, über dieselben 12.793.941 Aktien gemeinsame Stimm- und Verfügungsmacht zu besitzen und keine alleinige Stimm- oder Verfügungsmacht zu haben. Die Erklärung bestätigt, dass die Aktien im gewöhnlichen Geschäftsverkehr erworben wurden und nicht mit dem Ziel, die Kontrolle des Emittenten zu beeinflussen. Die Meldung enthält eine gemeinsame Einreichungsvereinbarung, die am 14. August 2025 unterzeichnet wurde.

Positive
  • Material, transparent disclosure of a 5.9% stake (12,793,941 shares) meeting SEC reporting requirements
  • Joint filing agreement and signatures provide clear accountability among reporting persons
  • Certification states holdings were acquired in the ordinary course of business and not to change control
Negative
  • Shared voting power across entities indicates consolidated influence even though no sole power is claimed
  • Potential for future activism remains since a 5.9% position is large enough to support engagement or nominations

Insights

TL;DR: A 5.9% stake is material and could attract investor attention but does not indicate control; monitor for further amendments.

The filing shows Gates Capital and affiliated entities hold a non‑controlling yet material stake in Neogen (NEOG). At 12.8 million shares and 5.9% of outstanding stock, this position exceeds the 5% disclosure threshold, signaling the firm considers this a significant economic interest. Shared voting and dispositive power across the reporting persons suggests centralized decision-making within the Gates group rather than fragmented ownership. The certification states the holdings are in the ordinary course of business and not intended to change control, which reduces immediate governance change risk. Investors should note the position size relative to free float and watch for Schedule 13D amendments or proxy activity that would signal activist intentions.

TL;DR: Joint filing discloses material ownership and centralized voting; no explicit control intent declared.

The disclosure is standard for an investment adviser and related entities acting as a group. All reporting persons disclose identical shared voting and dispositive power, and they executed a joint filing agreement, establishing joint responsibility for filings. The explicit certification that the stake was not acquired to influence control is legally relevant but not dispositive of future actions. From a governance perspective, a combined 5.9% stake gives the group standing to engage with management, request information, or nominate directors if they choose, though the filing currently indicates passive intent. Continued monitoring of amendments or communications is warranted to assess any shift toward active engagement.

Gates Capital e le entità correlate dichiarano la titolarità effettiva di 12.793.941 azioni ordinarie di Neogen Corporation, pari al 5,9% delle 217.205.186 azioni in circolazione al 30 giugno 2025. La comunicazione elenca Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; e Jeffrey L. Gates come soggetti che rendono la dichiarazione congiunta, ognuno dei quali dichiara di avere potere di voto e potere dispositivi condivisi sulle stesse 12.793.941 azioni e di non detenere alcun potere di voto o dispositivo in via esclusiva. La dichiarazione conferma che le azioni sono state acquisite nell'ambito dell'ordinaria attività d'impresa e non con l'intento di influenzare il controllo dell'emittente. Il deposito include un accordo di deposito congiunto firmato il 14 agosto 2025.

Gates Capital y entidades relacionadas informan la titularidad beneficiaria de 12.793.941 acciones ordinarias de Neogen Corporation, equivalentes al 5,9% de las 217.205.186 acciones en circulación al 30 de junio de 2025. La presentación enumera a Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; y Jeffrey L. Gates como informantes conjuntos, cada uno declarando tener poderes de voto y dispositivos compartidos sobre las mismas 12.793.941 acciones y no tener ningún poder de voto o dispositvo en forma exclusiva. La declaración afirma que las acciones se adquirieron en el curso ordinario del negocio y no con la intención de influir en el control del emisor. La presentación incluye un acuerdo de presentación conjunta firmado el 14 de agosto de 2025.

Gates Capital 및 관련 법인들은 네오젠 코퍼레이션 보통주 12,793,941주를 실질 소유하고 있음을 보고했으며, 이는 2025년 6월 30일 기준 발행주식 217,205,186주의 5.9%에 해당합니다. 신고서에는 Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; 및 Jeffrey L. Gates가 공동보고인으로 기재되어 있으며, 각자는 동일한 12,793,941주에 대해 공동 의결권 및 처분권을 보유하고 단독 의결권 또는 단독 처분권은 없다고 밝혔습니다. 성명서는 해당 주식이 통상적인 영업 과정에서 취득된 것이며 발행인의 지배에 영향을 미치기 위한 것이 아님을 확인합니다. 제출서에는 2025년 8월 14일 서명된 공동 제출 계약서가 포함되어 있습니다.

Gates Capital et des entités affiliées déclarent la propriété bénéficiaire de 12 793 941 actions ordinaires de Neogen Corporation, soit 5,9% des 217 205 186 actions en circulation au 30 juin 2025. Le dépôt mentionne Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; et Jeffrey L. Gates comme personnes faisant une déclaration conjointe, chacune déclarant détenir le pouvoir de vote et le pouvoir de disposition partagés sur les mêmes 12 793 941 actions et ne détenir aucun pouvoir de vote ni de disposition exclusif. La déclaration affirme que les actions ont été acquises dans le cours normal des affaires et non dans le but d'influencer le contrôle de l'émetteur. Le dossier inclut un accord de dépôt conjoint signé le 14 août 2025.

Gates Capital und verbundene Unternehmen melden ein wirtschaftliches Eigentum an 12.793.941 Stammaktien der Neogen Corporation, was 5,9% der 217.205.186 zum 30. Juni 2025 ausstehenden Aktien entspricht. Die Meldung führt Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; und Jeffrey L. Gates als gemeinsam meldende Personen auf, wobei jede Partei angibt, über dieselben 12.793.941 Aktien gemeinsame Stimm- und Verfügungsmacht zu besitzen und keine alleinige Stimm- oder Verfügungsmacht zu haben. Die Erklärung bestätigt, dass die Aktien im gewöhnlichen Geschäftsverkehr erworben wurden und nicht mit dem Ziel, die Kontrolle des Emittenten zu beeinflussen. Die Meldung enthält eine gemeinsame Einreichungsvereinbarung, die am 14. August 2025 unterzeichnet wurde.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Gates Capital Management, L.P.
Signature:/s/ Jeffrey L. Gates
Name/Title:Jeffrey L. Gates- President
Date:08/14/2025
Gates Capital Management GP, LLC
Signature:/s/ Jeffrey L. Gates
Name/Title:Jeffrey L. Gates- President
Date:08/14/2025
Gates Capital Management, Inc.
Signature:/s/ Jeffrey L. Gates
Name/Title:Jeffrey L. Gates- President
Date:08/14/2025
Jeffrey L. Gates
Signature:/s/ Jeffrey L. Gates
Name/Title:Jeffrey L. Gates
Date:08/14/2025
Exhibit Information

EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. DATE: August 14, 2025 Gates Capital Management, L.P. By: Gates Capital Management GP, LLC, its general partner By: Gates Capital Management, Inc., its managing member By: /s/ Jeffrey L. Gates Name: Jeffrey L. Gates Title: President Gates Capital Management GP, LLC By: Gates Capital Management, Inc., its managing member By: /s/ Jeffrey L. Gates Name: Jeffrey L. Gates Title: President Gates Capital Management, Inc. By: /s/ Jeffrey L. Gates Name: Jeffrey L. Gates Title: President Jeffrey L. Gates By: /s/ Jeffrey L. Gates

FAQ

How many Neogen (NEOG) shares does Gates Capital report owning?

The filing discloses 12,793,941 shares, representing 5.9% of Neogen's common stock outstanding as of June 30, 2025.

Do the reporting persons claim control of Neogen (NEOG)?

No. The filing states the shares were acquired in the ordinary course of business and not to change or influence control of the issuer.

Who are the reporting persons in this Schedule 13G for NEOG?

The reporting persons are Gates Capital Management, L.P.; Gates Capital Management GP, LLC; Gates Capital Management, Inc.; and Jeffrey L. Gates.

What voting and dispositive powers are reported?

Each reporting person discloses 0 sole voting/dispositive power and 12,793,941 shares of shared voting and shared dispositive power.

When was the Schedule 13G signed?

The joint filing agreement and signatures are dated August 14, 2025.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.14B
215.75M
0.38%
116.85%
8.43%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING